Abstract

BackgroundTNF inhibitors (TNFi) have proven to be effective in the treatment of rheumatoid arthritis (RA). They are however associated with side effects and high costs, making dose reduction or discontinuation...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
N Van Herwaarden ... A A Den Broeder
BMJ (Clinical research ed.) | VOL. 350
N Van Herwaarden, et. al.N Van Herwaarden ... A A Den Broeder
09 Apr 2015
AB0246 Predictive Value of a Multi-Biomarker Disease Activity Score for Successful Dose Reduction of TNF Inhibitors in Rheumatoid Arthritis: Results of the Dress Study
C Bouman ... A Van Der Maas
Annals of the Rheumatic Diseases | VOL. 74
C Bouman, et. al.C Bouman ... A Van Der Maas
01 Jun 2015
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Lise M Verhoef ... Aatke Van Der Maas
Cochrane Database of Systematic Reviews | VOL. 5
Lise M Verhoef, et. al.Lise M Verhoef ... Aatke Van Der Maas
24 May 2019
Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice
S Atalay ... E M G J De Jong
Journal of Dermatological Treatment | VOL. 33
S Atalay, et. al.S Atalay ... E M G J De Jong
06 Jan 2021
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions
Alena Pilková ... Martin Matoulek
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Alena Pilková, et. al.Alena Pilková ... Martin Matoulek
17 Jul 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management
Giulia Cancellieri ... Piera Polidori
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Giulia Cancellieri, et. al.Giulia Cancellieri ... Piera Polidori
15 Jul 2024
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?
Tien Thuy Ngo ... Charis Lau
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Tien Thuy Ngo, et. al.Tien Thuy Ngo ... Charis Lau
13 Jul 2024
View more papers